Oragenics, Inc. (OGEN) Net income 2016–2025
Oragenics, Inc. (OGEN) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$984.2MFY2025 · since FY2016: -$7.0M → -$984.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$984.2M | +6.9% |
| FY2024 | -$1.1B | -5016.2% |
| FY2023 | -$20.7M | -44.6% |
| FY2022 | -$14.3M | +9.1% |
| FY2021 | -$15.7M | +40.6% |
| FY2020 | -$26.4M | -69.8% |
| FY2019 | -$15.6M | -57.0% |
| FY2018 | -$9.9M | -47.3% |
| FY2017 | -$6.7M | +4.0% |
| FY2016 | -$7.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice